Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro

Clinical and Vaccine Immunology

Volumn 15, Issue 6, 2008, Pages 970-973

  Goldman, David L ^a   Zeng, WangYong ^a   Rivera, Johanna ^a   Nakouzzi, Antonio ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; MONOCLONAL ANTIBODY; PROTEINASE; TOXIN;

ANIMAL CELL; ARTICLE; BACILLUS ANTHRACIS; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HEAT TREATMENT; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SERUM;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELL DEATH; CELL LINE; HEAT; HUMANS; MACROPHAGES; MICE; PEPTIDE HYDROLASES;

EID: 47049121264     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00064-08     Document Type: Article

References (15)

1. Beall, F. A., and F. G. Dalldorf. 1966. The pathogenesis of the lethal effect of anthrax toxin in the rat. J. Infect. Dis. 116:377-389.
2. Bielinska, A. U., K. W. Janczak, J. J. Landers, P. Makidon, L. E. Sower, J. W. Peterson, and J. R. Baker, Jr. 2007. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Infect. Immun. 75:4020-4029.
3. Boyer, A. E., C. P. Quinn, A. R. Woolfitt, J. L. Pirkle, L. G. McWilliams, K. L. Stamey, D. A. Bagarozzi, J. C. Hart, Jr., and J. R. Barr. 2007. Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal. Chem. 79:8463-8470.
4. Busby, W. H., Jr., T. J. Nam, A. Moralez, C. Smith, M. Jennings, and D. R. Clemmons. 2000. The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. J. Biol. Chem. 275:37638-37644.
5. Culley, N. C., D. M. Pinson, A. Chakrabarty, M. S. Mayo, and S. M. Levine. 2005. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immun. 73:7006-7010.
6. Ezzell, J. W., Jr., and T. G. Abshire. 1992. Serum protease cleavage of Bacillus anthracis protective antigen. J. Gen. Microbiol. 138:543-549.
7. Falo, L. D., Jr., L. J. Colarusso, B. Benacerraf, and K. L. Rock. 1992. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:8347-8350.
8. Gorse, G. J., W. Keitel, H. Keyserling, D. N. Taylor, M. Lock, K. Alves, J. Kenner, L. Deans, and M. Gurwith. 2006. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Vaccine 24:5950-5959.
9. Kuo, S. R., M. C. Willingham, S. H. Bour, E. A. Andreas, S. K. Park, C. Jackson, N. S. Duesbery, S. H. Leppla, W. J. Tang, and A. E. Frankel. 2007. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb. Pathog. [Epub ahead of print.] doi:10.1016/j.micpath.2007. 12.001.
10. Mabry, R., K. Brasky, R. Geiger, R. Carrion, Jr., G. B. Hubbard, S. Leppla, J. L. Patterson, G. Georgiou, and B. L. Iverson. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13:671-677.
11. Moayeri, M., J. F. Wiggins, and S. H. Leppla. 2007. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect. Immun. 75:5175-5184.
12. Rivera, J., A. Nakouzi, N. Abboud, E. Revskaya, D. Goldman, R. J. Collier, E. Dadachova, and A. Casadevall. 2006. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infect. Immun. 74:4149-4156.
13. Rodriguez, G. M., and S. Diment. 1995. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur. J. Immunol. 25:1823-1827.
14. Singh, Y., K. R. Klimpel, N. Arora, M. Sharma, and S. H. Leppla. 1994. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J. Biol. Chem. 269:29039-29046.
15. Yamaguchi, K., H. Sakiyama, M. Matsumoto, H. Moriya, and S. Sakiyama. 1990. Degradation of type I and II collagen by human activated C1-s. FEBS Lett. 268:206-208.